Neoadjuvant chemotherapy for upfront resectable colorectal liver metastasis: Is it worthwhile?. // Clinical Surgical Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2773160X26000279?dgcid=rss_sd_all
Neoadjuvant chemotherapy for upfront resectable colorectal liver metastasis: Is it worthwhile?. Clinical Surgical Oncology. https://www.sciencedirect.com/science/article/pii/S2773160X26000279?dgcid=rss_sd_all
“Neoadjuvant chemotherapy for upfront resectable colorectal liver metastasis: Is it worthwhile?.” Clinical Surgical Oncology.
@article{article41519,
title = {Neoadjuvant chemotherapy for upfront resectable colorectal liver metastasis: Is it worthwhile?},
journal = {Clinical Surgical Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2773160X26000279?dgcid=rss_sd_all}
}
Publication date: November–December 2026 Source: Acta Otorrinolaringologica (English Edition), Volume 77, Issue 6 Author(s): Daniel Álvarez de Castro, Sandra Pérez de la Iglesia, Miguel Ramírez Verdyguer, Francisco José Manzano Gómez